TY  - JOUR
T1  - Interpreting Genomic Alterations to Understand Effectiveness and Adverse Reactions to Cancer Therapeutics: Insights from the Oncology Pharmacy Field
A1  - Mohammad Rezaei
A1  - Ali Karimi
A1  - Reza Mohammadi
A1  - Saeed Jalali
A1  - Hossein Farhadi
JF  - Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology
JO  - Spec J Pharmacogn Phytochem Biotechnol
SN  - 3062-441X
Y1  - 2022
VL  - 2
IS  - 1
DO  - 10.51847/fuflRMnfNT
SP  - 167
EP  - 177
N2  - This paper explores emerging areas of pharmacogenomics that are becoming increasingly relevant to contemporary oncology pharmacy practice. The literature examined for this review was primarily drawn from recently approved therapeutics issued by the U.S. Food and Drug Administration and from newly incorporated treatment protocols within the National Comprehensive Cancer Network. The discussion highlights major pharmacogenomic themes, such as genomic variations that shape drug biotransformation, influence therapeutic response, and modify molecular targets; it also integrates significant clinical developments to offer a comprehensive perspective. The expanding repertoire of pharmacogenomic tools provides a robust platform for practice evolution and signals a transformative movement toward highly individualized treatment strategies.
UR  - https://galaxypub.co/article/interpreting-genomic-alterations-to-understand-effectiveness-and-adverse-reactions-to-cancer-therape-kyxtyxh4fedpv3z
ER  -